99% and occlusion 100% and 94% respectively. The principal clinical value of ultrasound screening is to spare patients with "non-significant" stenosis the risk of unnecessary angiography. Thus a simple measure of the Duplex screening tests' performance is the proportion of all strokes occurring as a complication of angiography that are avoided by changing the investigation policy from "angiograms for all carotid TIA and minor ischaemic stroke patients" to "angiograms for all patients with abnormal ultrasound results". If Duplex scanning were used to select patients most likely to have a significant abnormality on angiography, depending on the degree of stenosis to be detected, 52-85% of angiographic strokes might be avoided. If the predictive equation were used 62-88% of angiographic strokes might be avoided.
There has been much debate recently about the place of carotid endarterectomy in the management of patients with carotid artery territory transient ischaemic attacks (TIAs) ." The lack of consensus on the value of endarterectomy in the United Kingdom is reflected in the enormous variation in the use of angiography by British neurologists when investigating patients with TIA; in the United Kingdom-TIA trial, some neurologists performed cerebral angiography on all patients entered in the trial, whereas others rarely performed it.2 Between 10% and 50% of patients referred to a neurological centre with carotid artery territory TIAs have a surgical lesion of the internal carotid artery (personal data and3 4). In such patients the risks of stroke after cerebral arterial angiography varies between 1% and 5%,"7 although the risk of permanent or disabling stroke is less (perhaps 0-3-4-74%) 67 Thus in centres where most patients with TIA have cerebral angiography, many of the angiograms will not demonstrate a severe enough lesion to justify surgery (or randomisation in one of the current randomised controlled trials of carotid endarterectomy), and therefore a large number of patients will have been unnecessarily, as it turns out for them, exposed to the risks of angiography.
Carotid ultrasound studies are increasingly used to screen patients to (1) + ve and -ve refer to whether the angiogram (see methods section for measurement method) showed a stenosis of greater or equal to 25% or less than 25% respectively. Tables 1, 2 and 3 give the data on the performance ofthe B mode image alone and the predictive model (image and flow data together) in the detection of different degrees of stenosis. With stenoses of less than 25%, the estimate from the B mode image scanner was not infrequently (13 arteries) more severe than the angiogram which accounted for the relatively reduced specificity of 85% and positive predictive value of 84%. For the detection of stenoses of 50% or greater, the sensitivity (94%), specificity (88%), positive predictive value (92%) and negative predictive value (97%) were higher. For stenoses of 75% or greater, the sensitivity of B mode imaging was lower (68%) though specificity was higher (99%). Table 4 gives the performance of duplex and flow data in the detection of internal carotid artery occlusion. Although the sensitivity, specificity and negative predictive values are very high (over 90%), there is a small number (10 arteries) in which the duplex scan and Doppler flow suggested the artery was occluded but the angiogram showed a tight stenosis.
The main value of non-invasive screening tests is to identify patients with normal arteries who can then be spared the 1-5% risk of stroke associated with cerebral angiography (we have based our calculations on an estimated risk of 2% If a single screening test on its own is unreliable, then it may be advantageous to include a second screening test.20 Table 5 shows that mathematically combining B mode imaging data with Doppler data will, at most levels of disease, improve sensitivity and specificity. This approach is more systematic than all previous attempts to combine data from the two tests.
Many methods yield an estimate of stenosis within a certain range (for example "50-75%"). This may be adequate for clinical purposes, but is less than ideal for follow up studies to assess progression ofcarotid stenosis. Physicians assessing the progress of treatment for hypertension would not be happy with a sphygmomanometer which gave readings of "80-100%" mmHg, so neurologists might perhaps reasonably demand greater accuracy of ultrasound screening, to yield a single figure (such as 55%) when assessing the progress of carotid stenosis. To provide such a single measurement we therefore developed a mathematical equation using multiple regression techniques, which appears to make a modest improvement in the performance of the test, either by cancelling out opposing errors in the two techniques, or by some other means. However, the equation has only been tested on the data from which it was derived. It is also only able to predict within the range of values in the original data set. It must now be tested in an independently collected set of patient data, preferably containing larger numbers of patients, and with more extreme values to fully test its performance in everyday practice. This work is in progress. The usefulness of the equation in long-term follow up studies is also being evaluated.
Despite the preliminary nature of the equation, we felt it would be informative to make some estimates of the likely impact of ultrasound techniques on the avoidance of strokes related to cerebral angiography for ischaemic cerebrovascular disease. In making these calculations, we have naturally had to make assumptions about the risks of stroke associated with angiography, the distribution of disease severity, and that the predictive equation would perform as well on other sets of patient data as it does on the data from which it was derived. Since the value of carotid surgery is unproven, we cannot introduce a counterbalancing "loss" ofstrokes occurring in the few cases who had negative screening tests yet had carotid disease severe enough to have benefited from surgery. 
